VASCULITIS PRODUCT HIGHLIGHTS

Similar documents
Autoimmune diagnostics. A comprehensive product line for the detection of autoantibodies

Autoantibodies panel ANA

Assays. New. New. Combinations. Possibilities. Patents: EP , AU

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Clinical Laboratory. [None

Simultaneous comprehensive multiplex autoantibody analysis by CytoBead technology for Rapidly Progressive Glomerulonephritis.

IMTEC-ANA-LIA MAXX. Design Verification

Anti-Nuclear Antibodies (ANA). (Incorporating Anti-double stranded DNA (dsdna) and Anti-Extractable Nuclear Antigen (ENA) Antibodies)

4. KIDNEYS AND AUTOIMMUNE DISEASE

PRODUCTS. Autoimmune Disease Antigens. Custom Design Antigens. Infectious Disease Antigens

University of Pretoria

Primary Sample Manual Immunology Issue No Effective Date: 06/11/17 Page 1 of 19 EUROFINS BIOMNIS. Pr. Conleth Feighery, Immunology Consultant

PRODUCT CATALOG. All products are CE marked

Rheumatologic Testing in Primary Care

Alida R Harahap & Farida Oesman Department of Clinical Pathology Faculty of Medicine, University of Indonesia

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.

Test Name Results Units Bio. Ref. Interval

ELISA Range. VIROTECH Diagnostics GmbH. Lot independent. Reagent. System. IgG-Conjugate. Substrate. IgM-Conjugate. Washing Solution.

Interpreting Rheumatologic Lab Tests

INTERPRETATION OF LABORATORY TESTS IN RHEUMATIC DISEASE

ANA Screen ELISA Kit. Cat. No.:DEIA3138 Pkg.Size:96T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided

Rhematologic serum testing is: Before request serologic tests, ANCA associated antigens c-anca: most commonly against the proteinase 3 (PR-3)

A Dual-Fixed Neutrophil Substrate Improves Interpretation of Antineutrophil Cytoplasmic Antibodies by Indirect Immunofluorescence

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

Publication of the Month 2003

Autoantibodies in the Idiopathic Inflammatory Myopathies

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.

Freiburg Medical Laboratory ME LLC, P.O.Box 3068, Dubai Tel: Fax:

Quality assessment service of the Institute for Quality Assurance Lübeck

Diagnostic Tests in Rheumatic Disease: What s Old, What s New & What s Useful? COPYRIGHT

EC Declaration of Conformity Authorised By: Version Released Amendments 3 04/03/2015

Autoantibodies giving rise to cytoplasmic IIF staining using HEp-2 cell substrate

Panel # Panel CPT Code Price 2010 AUTOIMMUNE PROFILE - BASIC 99.00

Detection of Anti-nuclear Antibodies in Women with Hyperprolactinaemia

Comparison of Performance of ELISA with Indirect Immunofluoresence for the Testing of Antinuclear Antibodies

PR3/MPO-ANCA is as effective as immunofluorescence as a first-line test in AAV screening

Differentiated ANCA diagnostics using BIOCHIP Mosaics

BlueBLOT-LINE Borrelia. Test Characteristics. Antibody Response

EDITORIAL. Issue Seventeen, October Editorial Team. Issue Seventeen. Info link

Small Vessel Vasculitis

IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease

THROMBOSIS PRODUCT HIGHLIGHTS

QUANTA Lite TM ANA ELISA

Supplementary Figure Legends

NOVA Lite ANCA (Ethanol) Kit with DAPI For In Vitro Diagnostic Use CLIA Complexity: High

Abstract. Immunopathology / ADDENDUM TO CONSENSUS STATEMENT ON TESTING AND REPORTING OF ANCA

Advances in Autoantibody Testing & Clinical Applications

PROFILES MENU. Page no. 9 Page no. 8 Page no. 7 Page no. 6 Page no. 5. Page no. 2. Page no. 4 Page no. 3

Is it Autoimmune or NOT! Presented to AONP! October 2015!

ANA-9-Line. Membrane based immunoblot for the semiquantitative determination of antinuclear autoantibodies. Instruction for use

IdentRA test panel with eta. A clinically proven biomarker for earlier, accurate RA diagnosis and now, prognosis and monitoring

Antibodies to selected minor target anti-neutrophil cytoplasmic antigens in systemic lupus patients

Rheumatologic Lab Tests

Disappearance of anti-mda-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission

Product Guide. Valid from June 15 th, Simply innovative diagnostics

Crescentic Glomerulonephritis (RPGN)

Approach to Glomerular Diseases: Clinical Presentation Nephrotic Syndrome Nephritis

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

DC were seeded into tissue culture dishes in IMDM 2% FCS, and added with PMN. (1:1; PMN: DC) for 16h also in the presence of DNAse (100 U/ml); DC were

International Journal of Pharma and Bio Sciences

LU:research Institutional Repository of Lund University

LABORATORY STANDARD IN THE DIAGNOSIS AND THERAPY MONITORING OF AUTOIMMUNE DISEASE: VASCULITIS

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Case Report A Case of Concurrent MPO-/PR3-Negative ANCA-Associated Glomerulonephritis and Membranous Glomerulopathy

Clinical features and outcome of patients with both ANCA and anti-gbm antibodies

The Power of the ANA. April 2018 Emily Littlejohn, DO MPH

Fatigue, persistence after Lyme borreliosis 196, 197 Francisella tularensis, see Tularemia

AbBaltis. Product Catalogue. Contact us now for free samples!

Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns


ENA screen (Extractable Nuclear Antigen) ELISA

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Methodological update How and why should we detect ANCA?

AN OVERVIEW OF ANCA-ASSOCIATED VASCULITIS

Autoimmune hepatitis

Anti-MPO ANCA-Associated Diffuse Alveolar Hemorrhage is Associated with Increased Mortality Compared to Anti-PR3 Disease

ANA Diagnostics Using Indirect Immunofluorescence

Publication of the Month 2005

AUTOANTIBODIES PRECEDING AUTOIMMUNE DISEASES

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

A historical essay on detection of anti-neutrophil cytoplasmic antibodies

Dr Ian Roberts Oxford

AUTOIMMUNE DISEASES. chronic and usually irreversible incidence: 5% - 7% of population, higher frequencies in women, increases with age

Medical Immunology Practice Questions-2016 Autoimmunity + Case Studies

J Sobajima, S Ozaki, H Uesugi, F Osakada, M Inoue, Y Fukuda, H Shirakawa, M Yoshida, A Rokuhara, H Imai, K Kiyosawa, K Nakao

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Beyond the next generation: data mining and T cells. Amanda Semper, Scientific Programmes Manager, PHE Rare and Imported Pathogens Laboratory

Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP

Autoimmunity. Autoimmune Disease

Autoimmune (AI) Disorders

Marilina Tampoia, MD; Vincenzo Brescia, MD; Antonietta Fontana, MD; Antonietta Zucano, PhD; Luigi Francesco Morrone, MD; Nicola Pansini, MD

Immune tolerance, autoimmune diseases

Scleritis LEN V KOH OD

Name and Intended Use

Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN RHEUMATOID ARTHRITIS PATIENTS

Transcription:

VASCULITIS PRODUCT HIGHLIGHTS AESKU.DIAGNOSTICS offers a comprehensive and complete diagnostic portfolio in the field of vasculitis diagnostics. Not only are screening and profiling s available but also does AESKU.DIAGNOSTICS supply the single parameters for the semi-quantitative analysis of patient sera. Complementing this, we also offer prime quality AESKUSLIDES and AESKUBLOTS which are an essential tool for the diagnosis of the respective vasculitis. ANCA Testing The anti-neutrophil cytoplasmic antibodies (ANCAs) consist of a range of antibodies which give rise to very specific immunofluorescence pattern termed C-ANCA (cytoplasmic) and P-ANCA (perinuclear) the cytoplasmic C-ANCA pattern is a typical pattern usually indicating the presence of anti-proteinase 3 (PR3) antibodies. The P-ANCA pattern, on the other hand, can be generated by antibodies against a plethora of antigens, the most important being antibodies against myeloperoxidase (MPO). In order to standardize the testing of ANCAs, a minimum requirement was defined in an international consensus statement (Savige et al. 1999). Here, ANCA testing demands an ELISA test following a positive IFT result. Furthermore, the European Vasculitis Study Group (EUVAS) showed that the diagnostic specificity increases to 99% when the IFT is combined with an antigen-specific ELISA: e.g. C-ANCA and PR3-ELISA; P-ANCA and MPO-ELISA (Hagen et al. 1998). EtOH formalin C-ANCA P-ANCA A-ANCA cytoplasmic perinuclear/nuclear cytoplasmic+perinuclear or very perinuclear C-ANCA P-ANCA ANA A-ANCA PR3 sensitive (REF 3302) 1. Coating with monoclonal antibody / bridging molecule 2. PR3 3. Serum incubation 4. Enzyme-conjugated anti-human IgG Direct ELISA Capture ELISA PR3 sensitive AESKU.DIAGNOSTICS scientists have developed an innovative method for the presentation of the antigen to the surface of the solid support, exposing a variety of relevant epitopes which would be hidden in the direct ELISAs, where the PR3 antigen is merely coated to the surface of the microtitre plate. This coating method, introduced in the PR3 sensitive production since 2001, exposes all relevant epitopes for the binding of ANCAs and has been shown to be superior to direct ELISAs and compare very favorably with ELISAs based on the antibody capture techniques. (Trevisin et al. 2008; Radice et al. 2009; Csernok et al. 2010). Hence, PR3 sensitive offers increased sensitivities and specificities compared to the commonly used direct ELISA setup. 36

VASCULITIS PRODUCT HIGHLIGHTS Vasculitis Screening (MPO+PR3) As an alternative to the IFT screening, AESKU.DIAGNOSTICS offers a screening test ( Vasculitis- Screen; REF 3323) which combines MPO and PR3 as antigens in one microtiter well for the rapid, simple and cost effective testing of ANCAs. ANCA PROFILE Since many ANCA patterns, especially the P-ANCAs, can be caused by a variety of additional antigens like lactoferrin, cathepsin G, elastase, lysozym and bactericidal/permeability increasing protein (BPI), AESKU.DIAGNOSTICS offers a profiling ELISA test ( ANCA-Pro; REF 3301) for the rapid differentiation of these parameter. To complete the portfolio, each of the profiling antigens can be quantified using the respective against Lactoferrin (REF 3307), Cathepsin G (REF 3306), Elastase (REF 3305), Lysozyme (REF 3308) and BPI (REF 3304). Clinical picture leading to vasculitis ANCA testing AESKUSLIDES IFA Vasculitis Screen AESKUBLOTS Vasculitis Pro NEGATIVE POSITIVE P-ANCA C-ANCA A-ANCA ANCA - Pro PR3 MPO GBM single parameters PR3 sensitive - MPO - BPI - Cathepsin G - Lactoferrin - Lysozyme - Elastase - GBM FINAL DIAGNOSIS / TREATMENT A definite clinical diagnosis should not be based on the results of the performed tests alone, but should be made by the physician after all clinical and laboratory findings have been evaluated. The diagnosis is to be verified using different diagnostic methods. 37

VASCULITIS REF 3301 ANCA-Pro 0-100 U/ml Profile-G Native human proteinase 3, myeloperoxidase, neutrophilic elastase, cathepsin G, lactoferrin, lysozyme, BPI (ELISA) for the separate semiquantitative or qualitative determination of IgG autoantibodies to 7 different cytoplasmic neutrophil antigens (PROFILE) in REF 3323 Vasculitis- Screen Screening-G Each well with native human MPO and PR3 (ELISA) for the combined quantitative and qualitative determination of IgG autoantibodies to myeloperoxidase (MPO) and proteinase 3 (PR3) in human serum (SCREENING) REF 3302 PR3 sensitive Native human proteinase 3 autoantibodies to proteinase 3 (PR3) in REF 3303 MPO Native human myeloperoxidase autoantibodies to myeloperoxidase (MPO) in REF 3304 BPI Native human BPI autoantibodies to BPI (bactericidal / permeability increasing protein) in 38

VASCULITIS REF 3305 Elastase Native human neutrophilic elastase autoantibodies to neutrophilic elastase in REF 3306 Cathepsin G Native human cathepsin G autoantibodies to cathepsin G in REF 3307 Lactoferrin Native human lactoferrin autoantibodies to lactoferrin in REF 3308 Lysozyme Native human lysozyme autoantibodies to lysozyme in REF 3309 GBM Recombinant human GBM autoantibodies to recombinant human glomerular basement membrane protein (GBM) in 39

AESKUBLOTS The AESKUBLOTS test line represents a variety of different immunoblots for efficient profile testing of autoimmune and infectious diseases. Coated with a selected panel of specific antigens on one test strip, AESKUBLOTS provide a complete diagnostic overview in a single test and are suitable for screening of autoimmune diseases as well as cost-effective differential diagnosis. For an easy automated processing the HELMED BLOT processor can be used. For an easy semi-quantitative and automatic interpretation of AESKUBLOTS, AESKU.SYSTEMS provides a dedicated evaluation software: AESKU.SCAN. REF 4001 ANA-17 Pro dsdna Nucleosome Histone SmD1 PCNA Rib-P0 SS-A/Ro 60kD SS-A/Ro 52 kd SS-B/La CENP-B Scl-70 U1-sn RNP AMA-M2 Jo-1 PM-Scl Mi-2 Ku AESKUBLOTS ANA-17 Pro Color-coded (orange) test strips with cut-off and positive control dsdna, nucleosomes, histones, SmD1, PCNA, Rib-P0, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, CENP-B, Scl-70, U1-sn RNP, AMA-M2, Jo-1, Pm-Scl, Ku and Mi-2 in. AESKUBLOTS ANA-17 Pro is used for the differential diagnosis of systemic rheumatic diseases. Detection of autoantibodies in AESKUBLOTS with the corresponding specific antigens allows an easier and more reliable differentiation of specific ANAs (anti-nuclear antibodies). The ANAs included occur in active and inactive systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjogren's syndrome, primary biliary cirrhosis (PBC) and polymyositis. ANA-17 Pro antigens are fitted on the test strip according to their relevance for the individual autoimmune disease (SLE, Sjogren's syndrome, CREST syndrome, scleroderma, MCTD, myositis, and PBC) allowing easier interpretation. REF 4000 ANA-12 Pro Nucleosome dsdna Histone SmD1 U1-snRNP SS-A/Ro 60kD SS-A/Ro 52 kd SS-B/La Scl-70 CENP-B Jo-1 Rib-PO AESKUBLOTS ANA-12 Pro Color-coded (yellow) test strips with cut-off and positive control nucleosomes, dsdna, histones, SmD1, U1-snRNP, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, Scl-70, CENP-B, Jo-1 and ribosomal P protein (Rib-P0) in. AESKUBLOTS ANA-12 Pro is used for the differential diagnosis of systemic rheumatic diseases. Detection of autoantibodies in AESKUBLOTS with the corresponding specific antigens allows an easier and more reliable differentiation of specific ANAs (anti-nuclear antibodies). The ANAs included occur in active and inactive systemic lupus erythematosus (SLE), mixed connective tissue diseases (MCTD), scleroderma, Sjogren's syndrome and polymyositis. 51

AESKUBLOTS REF 4004 Liver Pro AMA-M2 SP100 LKM1 Gp210 LC1 SLA AESKUBLOTS Liver Pro anti-human IgG HRP Color-coded (brown) test strips with cut-off and positive control AMA-M2, Sp100, LKM1, gp210, LC1 and SLA in. AESKUBLOTS Liver Pro is used as an aid in the diagnosis of autoimmune liver diseases. The most important autoimmune liver diseases are autoimmune hepatitis (AIH) types 1-3, primary biliary cirrhosis (PBC) and a combination of both diseases (immunocholangiopathy). AIH is a chronic, progressive liver disease of unknown cause, which responds well to immunosuppressive therapy, however, if untreated it has a poor prognosis. PBC is a chronic inflammatory disease of the small and medium-size bile ducts. Undetected it can lead to liver cirrhosis. An early and reliable diagnosis is therefore of great importance. REF 4003 Myositis Pro Jo-1 Mi-2 PM-Scl U1-snRNP Ku AESKUBLOTS Myositis Pro anti-human IgG HRP Color-coded (blue) test strips with cut-off and positive control Jo-1, Mi-2, Pm-Scl, U1-snRNP and Ku in. AESKUBLOTS Myositis Pro is designed to help in the diagnosis of poly- and dermatomyositis, as well as myositis-associated autoimmune diseases. Autoimmune myositis represents a heterogeneous group of acquired muscle diseases. Their main clinical and morphological characteristics are muscle weakness and inflammatory infiltration of skeletal muscles. REF 4002 Vasculitis Pro PR3 MPO GBM AESKUBLOTS Vasculitis Pro anti-human IgG HRP Color-coded (purple) test strips with cut-off and positive control PR3, MPO and GBM in. AESKUBLOTS Vasculitis Pro is used for the differential diagnosis of autoimmune vasculitis. Antibodies against proteinase 3 (PR3) and myeloperoxidase (MPO) belong to the group of anti-neutrophil cytoplasmic antibodies (ANCA), which have been described as important markers in the differential diagnosis of autoimmune vasculitis. Anti-PR3 antibodies represent specific serological markers for granulomatosis with polyangiitis (Wegener's) and could play a role in pathogenesis. Anti-MPO antibodies occur in idiopathic and vasculitis-associated rapidly progressive glomerulonephritis, they are found in up to 70% of microscopic polyangiitis, and up to 5-50% in the Churg-Strauss syndrome. Serological detection of circulating antibodies against glomerular basement membrane in the glomeruli (GBM) is the method of choice in diagnosis of Goodpasture's syndrome. 52

AESKUBLOTS REF 4005 Gastro Pro Gliadin Neo-tTg ASCA PCA Intrinsic Factor AESKUBLOTS Gastro Pro anti-human IgA/IgG HRP Color-coded (black) test strips with cut-off and positive control Immunoblot for the qualitative detection of IgA and IgG antibodies against: Gliadin, Neo-tTg, mannan (ASCA), parietal cells and Intrinsic factor-antigen. AESKUBLOTS Gastro Pro is designed to assist in the diagnosis of celiac disease, pernicious anemia and Crohn s Disease. Each section of the gastro-intestinal tract can be affected by autoimmune gastrointestinal diseases. Disease is often diagnosed years after occurence of initial symptoms and outcome is severe in many cases. Celiac patients often have an IgA deficiency. In order to avoid false-negative results, AESKUBLOTS Gastro Pro detects IgA and IgG antibodies. REF 4006 Borrelia IgG Conj. control Cut-off control p100 VIsE p58 p41 p39 OspA OspC p18 AESKUBLOTS Borrelia-G anti-human IgG HRP Color-coded (green) test strips with cut-off, positive and conjugate control Immunoblot for the qualitative detection of specific IgG against Borrelia burgdorferi in. The assays provide tools for confirmation of positive and borderline ELISA ( Borrelia-G) results, and are in accordance with the two stage testing procedure recommended by the German Society for Hygiene and Microbiology (DGHM). Lyme disease is a multisystemic disease caused by infection with the spirochete Borrelia burgdorferi, transmitted in Europe mainly by Ixodes ricinus (sheep tick). The antigens coated on the test strips are: p100, VlsE, p58, p41, p39, OspA, OspC and p18. REF 4007 Borrelia IgM Conj. control Cut-off control p100 VIsE p58 p41 p39 OspA OspC p18 AESKUBLOTS Borrelia-M anti-human IgM HRP Color-coded (green) test strips with cut-off, positive and conjugate control Immunoblot for the qualitative detection of specific IgM against Borrelia burgdorferi in. The assays provide tools for confirmation of positive and borderline ELISA ( Borrelia-M) results, and are in accordance with the two stage testing procedure recommended by the German Society for Hygiene and Microbiology (DGHM). Lyme disease is a multisystemic disease caused by infection with the spirochete Borrelia burgdorferi, transmitted in Europe mainly by Ixodes ricinus (sheep tick). The antigens coated on the test strips are: p100, VlsE, p58, p41, p39, OspA, OspC and p18. 53